LifeSci Capital Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $100

Futu NewsDec 27, 2024 22:32 · Ratings

Clear Street Launches Healthcare & Biotechnology Equity Research

BusinesswireDec 18, 2024 03:00

Janux Therapeutics Price Target Maintained With a $200.00/Share by Cantor Fitzgerald

Dow JonesDec 12, 2024 00:37 · Ratings

Janux Therapeutics Analyst Ratings

BenzingaDec 12, 2024 00:25 · Ratings

BTIG Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $100

Futu NewsDec 10, 2024 18:36 · Ratings

BTIG Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)

TipRanksDec 10, 2024 18:27 · Ratings